Werner Muller-Esterl
Overview
Explore the profile of Werner Muller-Esterl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
2281
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Piiper A, Dikic I, Lutz M, Leser J, Kronenberger B, Elez R, et al.
J Biol Chem
. 2020 Oct;
295(43):14792.
PMID: 33097650
No abstract available.
2.
Kenne E, Rasmuson J, Renne T, Vieira M, Muller-Esterl W, Herwald H, et al.
FASEB J
. 2018 Oct;
33(2):2599-2609.
PMID: 30281335
Neutrophil recruitment and plasma exudation are key elements in the immune response to injury or infection. Activated neutrophils stimulate opening of the endothelial barrier; however, the underlying mechanisms have remained...
3.
Hoffmeister M, Prelle C, Kuchler P, Kovacevic I, Moser M, Muller-Esterl W, et al.
PLoS One
. 2014 Dec;
9(12):e116150.
PMID: 25546391
Holoprosencephaly is a common developmental disorder in humans characterised by incomplete brain hemisphere separation and midface anomalies. The etiology of holoprosencephaly is heterogeneous with environmental and genetic causes, but for...
4.
Kovacevic I, Hu J, Siehoff-Icking A, Opitz N, Griffin A, Perkins A, et al.
EMBO J
. 2012 Jul;
31(15):3309-22.
PMID: 22751148
F-BAR proteins are multivalent adaptors that link plasma membrane and cytoskeleton and coordinate cellular processes such as membrane protrusion and migration. Yet, little is known about the function of F-BAR...
5.
Cote J, Bovenzi V, Savard M, Dubuc C, Fortier A, Neugebauer W, et al.
PLoS One
. 2012 May;
7(5):e37485.
PMID: 22629405
Treatment of malignant glioma with chemotherapy is limited mostly because of delivery impediment related to the blood-brain tumor barrier (BTB). B1 receptors (B1R), inducible prototypical G-protein coupled receptors (GPCR) can...
6.
Oschatz C, Maas C, Lecher B, Jansen T, Bjorkqvist J, Tradler T, et al.
Immunity
. 2011 Feb;
34(2):258-68.
PMID: 21349432
Activated mast cells trigger edema in allergic and inflammatory disease. We report a paracrine mechanism by which mast cell-released heparin increases vascular permeability in vivo. Heparin activated the protease factor...
7.
Akesson P, Herwald H, Rasmussen M, Hakansson K, Abrahamson M, Hasan A, et al.
Microbiology (Reading)
. 2010 Aug;
156(Pt 12):3660-3668.
PMID: 20705662
Since the late 1980s, a worldwide increase of severe Streptococcus pyogenes infections has been associated with strains of the M1 serotype, strains which all secrete the streptococcal inhibitor of complement-mediated...
8.
Trabold R, Eros C, Zweckberger K, Relton J, Beck H, Nussberger J, et al.
J Cereb Blood Flow Metab
. 2009 Sep;
30(1):130-9.
PMID: 19773800
Inflammatory mechanisms are known to contribute to the pathophysiology of traumatic brain injury (TBI). Since bradykinin is one of the first mediators activated during inflammation, we investigated the role of...
9.
Schmidt M, Bicker F, Nikolic I, Meister J, Babuke T, Picuric S, et al.
Nat Cell Biol
. 2009 Jun;
11(7):873-80.
PMID: 19503073
Epidermal growth factor-like domain 7 (EGFL7) is a secreted factor implicated in cellular responses such as cell migration and blood vessel formation; however the molecular mechanisms underlying the effects of...
10.
Kahn R, Hellmark T, Leeb-Lundberg L, Akbari N, Todiras M, Olofsson T, et al.
J Immunol
. 2009 Jun;
182(12):7906-15.
PMID: 19494315
The kinin-forming pathway is activated on endothelial cells and neutrophils when high-molecular weight kininogen (HK) is cleaved by plasma kallikrein liberating bradykinin, a potent mediator of inflammation. Kinins are released...